Article

HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts

Departments of International Health and Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.
Infectious disorders drug targets 03/2011; 11(2):167-74. DOI: 10.2174/187152611795589663
Source: PubMed

ABSTRACT

Poor adherence to combined antiretroviral therapy (cART) has been shown to be a major determinant of virologic failure, emergence of drug resistant virus, disease progression, hospitalizations, mortality, and health care costs. While high adherence levels can be achieved in both resource-rich and resource-limited settings following initiation of cART, long-term adherence remains a challenge regardless of available resources. Barriers to optimal adherence may originate from individual (biological, socio-cultural, behavioral), pharmacological, and societal factors. Although patients and providers should continuously strive for maximum adherence to cART, there is accumulating evidence that each class of antiretroviral therapy has specific adherence-drug resistance relationship characteristics allowing certain regimens more flexibility than others. There is not a universally accepted measure for cART adherence, since each method has distinct advantages and disadvantages including cost, complexity, accuracy, precision, intrusiveness and bias. Development of a real-time cART adherence monitoring tool will enable the development of novel, pre-emptive adherence-improving strategies. The application of these strategies may ultimately prove to be the most cost-effective method to reduce morbidity and mortality for the individual and decrease the likelihood of HIV transmission and emergence of resistance in the community.

Download full-text

Full-text

Available from: Vincent C Marconi, Jan 07, 2015
  • Source
    • "For ALHIV, this shift underscores the importance of strengthening the delivery of adolescent HIV care. Generally , ART adherence rates between 95% and 100% are required to achieve viral suppression, and prevent drug resistance, disease progression, and AIDS mortality (Bakanda et al., 2011; Musiime et al., 2013; Nachega et al., 2011; Sebunya, Musiime, Kitaka, & Ndeezi, 2013). Globally, documented ART adherence rates among ALHIV vary widely, from 49% to 100%, depending on the method of assessment (Vreeman, Wiehe, Pearce, & Nyandiko, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Psychological distress is common among adolescents living with HIV (ALHIV) worldwide, and has been associated with non-adherence to anti-retroviral therapy (ART), leading to poor virologic suppression, drug resistance, and increased risk for AIDS morbidity and mortality. However, only a few studies have explored the relationship between psychological distress and ART adherence among adolescents in sub-Saharan Africa. The paper examines the relationship between psychological distress and ART adherence, and effect of psychosocial resources on ART adherence. We conducted a cross-sectional survey of 464 ALHIV (aged 12–19; 53% female) seeking HIV care at a large HIV treatment center in Kampala, Uganda. ALHIV were recruited during routine clinic visits. Three self-reported binary adherence measures were utilized: missed pills in the past three days, non-adherence to the prescribed medical regimen, and self-rated adherence assessed using a visual analog scale. Psychological distress was measured as a continuous variable, and computed as the mean score on a locally developed and validated 25-item symptom checklist for Ugandan ALHIV. Psychosocial resources included spirituality, religiosity, optimism, social support, and coping strategies. After adjusting for respondents’ socio-demographic characteristics and psychosocial resources, a unit increase in psychological distress was associated with increased odds of missing pills in past 3 days (Odds Ratio(OR) = 1.75; Confidence Interval (CI): 1.04–2.95), not following the prescribed regimen (OR = 1.63; CI: 1.08–2.46), and lower self-rated adherence (OR = 1.79; CI: 1.19–2.69). Psychosocial resources were associated with lower odds for non-adherence on all three self-report measures. There is a need to strengthen the psychosocial aspects of adolescent HIV care by developing interventions to identify and prevent psychological distress among Ugandan ALHIV.
    Full-text · Article · Jan 2016 · AIDS Care
  • Source
    • "Long-term adherence to antiretroviral treatment (ART) is a challenge in children, and children have lower virological suppression rates on ART compared to adults (Davies et al., 2011; Kamya et al., 2007). Adherence decreases over time, and may be linked to caregiver " treatment fatigue " and depression (Byakika-Tusiime et al., 2009; Nachega et al., 2011). Paediatric ART formulations may have complex dosage schedules which increase the difficulty with adherence. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Adherence to antiretroviral treatment (ART) is a challenge in childhood, and children on ART have reduced virological suppression compared to adults. This study evaluated the effect of community-based adherence support (CBAS) on virological outcomes amongst children receiving ART in four South African provinces. Patient Advocates are lay CBAS workers who provide adherence and psychosocial support for patients, undertaking home visits to address household challenges affecting adherence. Patient Advocates provide counselling for children's carers regarding adherence and psychosocial problems. A multicentre cohort study using routinely collected data was conducted at 57 public ART sites including ART-naive children (
    Full-text · Article · Nov 2013 · AIDS Care
  • Source
    • "Moreover, HIV transmission risks are reduced substantially in patients with lower viral loads, which is beneficial from a public health perspective [3-5]. Although full viral suppression can be achieved by (some) patients with lower adherence levels (70-90%) [6-8], it is generally recommended that patients take at least 90-95% of their medication for long-term suppression of viral replication, to minimise the risk of developing viral resistance [9-11]. Meta-analyses have shown that the quality of adherence support delivered by health care professionals during usual care is key to achieving adequate adherence levels and viral suppression [12,13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-adherence to HIV-treatment can have a negative impact on patients treatment success rates, quality of life, infectiousness, and life expectancy. Few adherence interventions have shown positive effects on adherence and/or virologic outcomes. The theory- and evidence-based Adherence Improving self-Management Strategy (AIMS) is an intervention that has been demonstrated to improve adherence and viral suppression rates in a randomised controlled trial. However, evidence of its cost-effectiveness is lacking. Following a recent review suggesting that cost-effectiveness evaluations of adherence interventions for chronic diseases are rare, and that the methodology of such evaluations is poorly described in the literature, this manuscript presents the study protocol for a multi-centre trial evaluating the effectiveness and cost-effectiveness of AIMS among a heterogeneous sample of patients. The study uses a multi-centre randomised controlled trial design to compare the AIMS intervention to usual care from a societal perspective. Embedded in this RCT is a trial-based and model-based economic evaluation. A planned number of 230 HIV-infected patients are randomised to receive either AIMS or usual care. The relevant outcomes include changes in adherence, plasma viral load, quality of life, and societal costs. The time horizon for the trial-based economic evaluation is 12-15 months. Costs and effects are extrapolated to a lifetime horizon for the model-based economic evaluation. The present multicentre RCT is designed to provide sound methodological evidence regarding the effectiveness and cost-effectiveness of a nurse-based counselling intervention (AIMS) to support treatment adherence among a large and heterogeneous sample of HIV-infected patients in the Netherlands. The objective of the current paper is to describe the trial protocol in sufficient detail to allow full evaluation of the quality of the study design. It is anticipated that, if proven cost-effective, AIMS can contribute to improved evidence-based counselling guidelines for HIV-nurses and other health care professionals. The study has been registered on clinicaltrials.gov (Identifier: NCT01429142).
    Full-text · Article · Jul 2013 · BMC Health Services Research
Show more